Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Daiichi Sankyo
Chinese Patent Office
Harvard Business School
Queensland Health

Generated: July 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2016)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Amgen Inc. v. Hospira, Inc.
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .
Biologic Drugs cited in Amgen Inc. v. Hospira, Inc.
The biologic drugs covered by the patents cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .

Details for Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-07-08 13 actual [1] - 13:19 27:10, 29:11, 34:9, 18:3, 18:7, 25:19, BPCIA […19, 24:6, 24:10, 29:11 … a bar for patents 24 those patents. And they should have listed the patents on the …one count of patent infringement under 35 U.S.C. § 271(e)(2)(C) and two counts of patent infringement…’s product. Specifically, U.S. Patent No. 5,756,349 (the “’349 Patent”) is directed to cells which are External link to document
2016-07-18 14 interest in U.S. Patent No. 5,756,349 (“the ’349 Patent”). 73. The ’349 Patent is titled “Production…preparing the same. B. U.S. Patent No. 5,756,349 72. Amgen Inc. is the owner … (INFRINGEMENT OF U.S. PATENT NO. 5,756,349 UNDER 35 …interest in U.S. Patent No. 5,856,298 (“the ’298 Patent”). 69. The ’298 Patent is titled “Erythropoietin… with respect to these patents or include these patents in an immediate patent-infringement suit, as contemplated External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
Chinese Patent Office
US Department of Justice
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.